Diabetes Clinical Trials in Orlando, FL

43 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Fenofibrate for Prevention of DR Worsening	Phase 3	Jaeb Center for Health Research	<1 mi
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus	Phase 2	Sun Pharmaceutical Industries Limited	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	<1 mi
Capability Assessment for Diet and Activity (CADA) Model for Diabetes	—	University of Central Florida	<1 mi
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)	Phase 2	Sanofi	<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics	—	Milton S. Hershey Medical Center	<1 mi
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes	N/A	Endogenex, Inc.	<1 mi
SPYRAL GEMINI Pilot Study	N/A	Medtronic Vascular	<1 mi
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus	Phase 2	Hanmi Pharmaceutical Company Limited	<1 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)	Phase 3	Eli Lilly and Company	<1 mi
The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults	N/A	AdventHealth Translational Research Institute	<1 mi
Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes	—	Nemours Children's Clinic	<1 mi
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease	Phase 2	Regeneron Pharmaceuticals	<1 mi
Transdisciplinary Care for Young Adults With Type 1 Diabetes	N/A	Nemours Children's Clinic	<1 mi
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial	N/A	Sonavex, Inc.	<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms	—	Milton S. Hershey Medical Center	<1 mi
Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency	Phase 1	Sun Pharmaceutical Industries Limited	<1 mi
Closed Loop and Education for Hypoglycemia Awareness Restoration	N/A	Milton S. Hershey Medical Center	<1 mi
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	<1 mi
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease	Phase 3	Alessandro Doria	<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis	Phase 2/3	CSL Behring	<1 mi
Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis	N/A	AdventHealth Translational Research Institute	<1 mi
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets	Phase 2	Biomea Fusion Inc.	5 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes	Phase 3	Eli Lilly and Company	5 mi
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes	Phase 3	Sanofi	5 mi
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus	Phase 2	Corxel Pharmaceuticals	5 mi
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes	Phase 2	Novo Nordisk A/S	10 mi
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies	—	AstraZeneca	10 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes	Phase 3	Novo Nordisk A/S	10 mi
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	10 mi
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)	Phase 3	Pfizer	12 mi
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide	Phase 2	Eli Lilly and Company	14 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease	Phase 3	Prokidney	19 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	24 mi
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes	Phase 3	Kailera	29 mi
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes	Phase 3	Kailera	29 mi
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL	Phase 4	HealthTech Wound Care	34 mi
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease	Phase 2	Novo Nordisk A/S	42 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)	Phase 2	Sparrow Pharmaceuticals	43 mi
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes	Phase 2	Housey Healthcare ULC	43 mi
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes	Phase 3	Hoffmann-La Roche	48 mi
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin	Phase 2	Eli Lilly and Company	49 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.